Friedreich’s ataxia is an autosomal recessive disorder characterized by impaired mitochondrial function, resulting in oxidative stress. In this study, we aimed at evaluating whether tocotrienol, a phytonutrient that diffuses easily in tissues with saturated fatty layers, could complement the current treatment with idebenone, a quinone analogue with antioxidant properties. Five young Friedreich’s ataxia patients received a low-dose tocotrienol supplementation (5 mg/kg/day), while not discontinuing idebenone treatment. Several oxidative stress markers and biological parameters related to oxidative stress were evaluated at the time of initiation of treatment and 2 and 12 months post-treatment. Some oxidative stress-related parameters and some inflammation indices were altered in Friedreich’s ataxia patients taking idebenone alone and tended to be normal values following tocotrienol supplementation; likewise, a cardiac magnetic resonance study showed some improvement following one-year tocotrienol treatment. The pathway by which tocotrienol affects the Nrf2 modulation of hepcidin gene expression, a peptide involved in iron handling and in inflammatory responses, is viewed in the light of the disruption of the iron intracellular distribution and of the Nrf2 anergy characterizing Friedreich’s ataxia. This research provides a suitable model to analyze the efficacy of therapeutic strategies able to counteract the excess free radicals in Friedreich’s ataxia, and paves the way to long-term clinical studies.

Bolotta, A., Pini, A., Abruzzo, P.M., Ghezzo, A., Modesti, A., Gamberi, T., et al. (2020). Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology. EXPERIMENTAL BIOLOGY AND MEDICINE, 245(3), 201-212 [10.1177/1535370219890873].

Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology

Bolotta, Alessandra;Abruzzo, Provvidenza M
;
Ghezzo, Alessandro;Bugamelli, Francesca;Zucchini, Cinzia;Marini, Marina
2020

Abstract

Friedreich’s ataxia is an autosomal recessive disorder characterized by impaired mitochondrial function, resulting in oxidative stress. In this study, we aimed at evaluating whether tocotrienol, a phytonutrient that diffuses easily in tissues with saturated fatty layers, could complement the current treatment with idebenone, a quinone analogue with antioxidant properties. Five young Friedreich’s ataxia patients received a low-dose tocotrienol supplementation (5 mg/kg/day), while not discontinuing idebenone treatment. Several oxidative stress markers and biological parameters related to oxidative stress were evaluated at the time of initiation of treatment and 2 and 12 months post-treatment. Some oxidative stress-related parameters and some inflammation indices were altered in Friedreich’s ataxia patients taking idebenone alone and tended to be normal values following tocotrienol supplementation; likewise, a cardiac magnetic resonance study showed some improvement following one-year tocotrienol treatment. The pathway by which tocotrienol affects the Nrf2 modulation of hepcidin gene expression, a peptide involved in iron handling and in inflammatory responses, is viewed in the light of the disruption of the iron intracellular distribution and of the Nrf2 anergy characterizing Friedreich’s ataxia. This research provides a suitable model to analyze the efficacy of therapeutic strategies able to counteract the excess free radicals in Friedreich’s ataxia, and paves the way to long-term clinical studies.
2020
Bolotta, A., Pini, A., Abruzzo, P.M., Ghezzo, A., Modesti, A., Gamberi, T., et al. (2020). Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology. EXPERIMENTAL BIOLOGY AND MEDICINE, 245(3), 201-212 [10.1177/1535370219890873].
Bolotta, Alessandra; Pini, Antonella; Abruzzo, Provvidenza M; Ghezzo, Alessandro; Modesti, Alessandra; Gamberi, Tania; Ferreri, Carla; Bugamelli, Fran...espandi
File in questo prodotto:
File Dimensione Formato  
Main ManuscriptELife.pdf

accesso aperto

Tipo: Postprint
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 547.13 kB
Formato Adobe PDF
547.13 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/708122
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 8
social impact